Exact Mass: 1026.3428529999999
Exact Mass Matches: 1026.3428529999999
Found 24 metabolites which its exact mass value is equals to given mass value 1026.3428529999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bromelain
C39H66N2O29 (1026.3751066000002)
ManXylManGlcNAcFucGlcNAc
C39H66N2O29 (1026.3751066000002)
[Chemical] Source; carrot glycoprotein
POLY(CYCLOPENTYLSILSESQUIOXANE), METHACRYLOXYPROPYL SUBSTITUTED
Carvedilol phosphate
C48H60N4O17P2 (1026.3428529999999)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
Carbohydrate moiety of bromelain
C39H66N2O29 (1026.3751066000002)
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Fucalpha1-3[Manalpha1-3(Xylbeta1-2)Manbeta1-4GlcNAcbeta]1-4GlcNAcbeta
C39H66N2O29 (1026.3751066000002)
Xylf(b1-2)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc
C39H66N2O29 (1026.3751066000002)
Fucalpha1-6[Manalpha1-3(Xylbeta1-2)Manbeta1-4GlcNAcbeta1-4]GlcNAcbeta
C39H66N2O29 (1026.3751066000002)
Xyl(b1-2)[Man(b1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Xyl(b1-2)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(b1-3)]b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Xylf(b1-2)[Fuc(a1-3)][Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
C39H66N2O29 (1026.3751066000002)
Xyl(b1-2)[Man(b1-3)]Man(b1-4)GlcNAc(a1-4)[Fuc(b1-3)]b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Xylf(b1-2)[Fuc(a1-3)][Man(a1-6)]Man(b1-4)GlcNAc(b1-4)b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Xyl(b1-2)[Fuc(a1-3)][Man(a1-6)]Man(b1-4)GlcNAc(b1-4)b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Xylf(b1-2)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Fucalpha1-3[Manalpha1-3(Xylbeta1-2)Manbeta1-4GlcNAcbeta]1-4GlcNAc
C39H66N2O29 (1026.3751066000002)
L-Xyl(b1-2)[Man(a1-6)]L-Man(b1-4)GlcNAc(b1-4)[D-Fuc(a1-3)]b-GlcNAc
C39H66N2O29 (1026.3751066000002)
n-(5-{[4,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxy-2-({6-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl}oxy)-6-(hydroxymethyl)oxan-3-yl)ethanimidic acid
C39H66N2O29 (1026.3751066000002)
n-[(3r,4r,5s,6r)-5-{[(2s,3r,4r,5s,6r)-5-{[(2s,3s,4s,5s,6r)-4,5-dihydroxy-6-({[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxy-6-(hydroxymethyl)-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]ethanimidic acid
C39H66N2O29 (1026.3751066000002)